arbaprostil at doses with varying effects on gastric acid secretion ( 25 and 50 micrograms ) was documented in these trials to be an effective and safe agent for healing gastric mucosal damage associated with aspirin or other nonsteroidal antiinflammatory drugs in patients with either rheumatoid arthritis or osteoarthritis without adversely affecting joint symptomatology .
C0004057
aspirin
C0029408
osteoarthritis